Table 2.
The baseline data for patients with IgAN and healthy controls.
| Characters | IgAN (n = 40) | Healthy controls (n = 40) | p value |
|---|---|---|---|
| Male/female | 22/18 | 20/20 | .83 |
| Age (mean ± SD, year） | 38 ± 11 | 37 ± 12 | .80 |
| SBP (mmHg, mean ± SD) | 128 ± 16 | 125 ± 16 | .77 |
| Proteinuria (g/d, median, IQR) | 1.23 (0.43–3.84) | ||
| Plasma IgA1 (μg/mL, median, IQR) | 1815 (1565–2583) | 1397 (840–1758) | .03 |
| eGFR (mL/min/1.73 m2) | 82.81 ± 25.78 | ||
| Oxford classification (%) | |||
| M score (M0/M1) | 6 (15)/34 (85) | ||
| E score (E0/E1) | 28 (70)/12 (30) | ||
| S score (S0/S1) | 22 (55)/18 (45) | ||
| T score (T0/T1/T2) | 18 (45)/18 (45)/4 (10) | ||
| C score (C0/C1/C2) | 10 (25)/22 (55)/8 (20) |
eGFR: estimated glomerular filtration rate; IQR: interquartile range; SBP: systolic blood pressure; SD: standard deviation.